Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
|Articles|July 17, 2011
Poll: How Do You Manage Shoulder Dystocia?
Author(s)OBGYN.net Staff
Although the incidence of shoulder dystocia is low (reported between 0.6% and 1.4%), it continues to be a clinical challenge for birth attendants and is among the 4 largest causes of monetary awards in obstetric tort cases.
Advertisement
Although the incidence of shoulder dystocia is low (reported between 0.6% and 1.4%), it continues to be a clinical challenge for birth attendants and is among the 4 largest causes of monetary awards in obstetric tort cases. A recent
Advertisement
Related to this article
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
FAQ: Who is a candidate for testosterone therapy in women?
3
FAQ: What does the evidence show about testosterone in women?
4
Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removals
5